» Articles » PMID: 38584913

Socioeconomic Inequalities in Healthcare System Efficiency in Japan During COVID-19 Pandemic: an Analysis of the Moderating Role of Vaccination

Overview
Specialty Public Health
Date 2024 Apr 8
PMID 38584913
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In the context of the COVID-19 pandemic, limited research has focused on socioeconomic disparities in Local Healthcare System Efficiency (LHSE) among Japanese prefectures. This study seeks to investigate the moderating impact of vaccination on the relationship between LHSE and socioeconomic characteristics and endowments.

Methods: To explore these relationships, we first utilized the Data Envelopment Analysis with Slack-Based Measure to measure the LHSE, based on data from Japanese prefectures during waves 2 to 5 of the pandemic. Then estimating the impact of socioeconomic variables on LHSE. Finally, we assessed the changes in the way socioeconomic variables affect LHSE before and after vaccine deployment using the Seemingly Unrelated Estimation t-test methodology.

Results: The research findings suggest an overall reduction in LHSE disparities across various regions due to the utilization of vaccines. Particularly in areas with relatively nsufficient bed resources, a significant improvement in LHSE was observed in most regions. However, there was no evidence supporting the role of vaccine deployment in mitigating socioeconomic inequalities in LHSE. Conversely, the utilization of vaccines showed a positive correlation between the improvement in LHSE and the proportion of older adult population in regions with sufficient bed resources. In regions facing bed shortages, the enhancement of LHSE became more reliant on reducing the occupancy rate of secured beds for severe cases after the introduction of vaccination.

Discussion: In regions facing bed shortages, the enhancement of LHSE became more reliant on reducing the occupancy rate of secured beds for severe cases. This underscores the importance for policymakers and implementers to prioritize the treatment of severe cases and ensure an effective supply of medical resources, particularly secured beds for severe cases, in their efforts to improve LHSE, in the post-COVID-19 era with rising vaccine coverage.

References
1.
Lupu D, tiganasu R . COVID-19 and the efficiency of health systems in Europe. Health Econ Rev. 2022; 12(1):14. PMC: 8841084. DOI: 10.1186/s13561-022-00358-y. View

2.
Brandal L, MacDonald E, Veneti L, Ravlo T, Lange H, Naseer U . Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021. Euro Surveill. 2021; 26(50). PMC: 8728491. DOI: 10.2807/1560-7917.ES.2021.26.50.2101147. View

3.
Kamegai K, Hayakawa K . Towards the light at the end of the tunnel: Changes in clinical settings and political measures regarding COVID-19 from 2021, and future perspectives in Japan. Glob Health Med. 2023; 4(6):327-331. PMC: 9773222. DOI: 10.35772/ghm.2022.01071. View

4.
Karako K, Song P, Chen Y, Karako T . An average of nearly 200,000 new infections per day over a six-week period: What is the impact of such a severe COVID-19 pandemic on the healthcare system in Japan?. Biosci Trends. 2022; 16(5):371-373. DOI: 10.5582/bst.2022.01390. View

5.
Okamoto S . State of emergency and human mobility during the COVID-19 pandemic in Japan. J Transp Health. 2022; 26:101405. PMC: 9167861. DOI: 10.1016/j.jth.2022.101405. View